Cargando…
Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research
Coronavirus disease 2019 (COVID-19) was declared to be a global pandemic by the World Health Organization on March 11, 2020. On April 7, 2020, a state of emergency was declared in Japan, as had been by other nations worldwide. This unprecedented crisis has profound implications for patients undergoi...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576109/ https://www.ncbi.nlm.nih.gov/pubmed/33085057 http://dx.doi.org/10.1007/s10147-020-01806-7 |
_version_ | 1783597949539844096 |
---|---|
author | Takahari, Daisuke Shinozaki, Eiji Wakatsuki, Takeru Ooki, Akira Ozaka, Masato Suzuki, Takeshi Nakayama, Izuma Osumi, Hiroki Kamiimabeppu, Daisaku Sato, Taro Ogura, Mariko Suenaga, Mitsukuni Chin, Keisho Yamaguchi, Kensei |
author_facet | Takahari, Daisuke Shinozaki, Eiji Wakatsuki, Takeru Ooki, Akira Ozaka, Masato Suzuki, Takeshi Nakayama, Izuma Osumi, Hiroki Kamiimabeppu, Daisaku Sato, Taro Ogura, Mariko Suenaga, Mitsukuni Chin, Keisho Yamaguchi, Kensei |
author_sort | Takahari, Daisuke |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19) was declared to be a global pandemic by the World Health Organization on March 11, 2020. On April 7, 2020, a state of emergency was declared in Japan, as had been by other nations worldwide. This unprecedented crisis has profound implications for patients undergoing chemotherapy and for practicing healthcare professionals. Various reports have shown data indicating that cancer patients with COVID-19 have high morbidity and mortality rates. In order to reduce the use of medical resources to avoid the risk of COVID-19 infections in both cancer patients and health care providers, oncologists now have to draw the line for cancer treatments by maintaining their efficacy while avoiding severe adverse events. In this article, we outlined the decisions made regarding the practice of gastrointestinal oncology in our institution during the COVID pandemic. |
format | Online Article Text |
id | pubmed-7576109 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-75761092020-10-21 Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research Takahari, Daisuke Shinozaki, Eiji Wakatsuki, Takeru Ooki, Akira Ozaka, Masato Suzuki, Takeshi Nakayama, Izuma Osumi, Hiroki Kamiimabeppu, Daisaku Sato, Taro Ogura, Mariko Suenaga, Mitsukuni Chin, Keisho Yamaguchi, Kensei Int J Clin Oncol Original Article Coronavirus disease 2019 (COVID-19) was declared to be a global pandemic by the World Health Organization on March 11, 2020. On April 7, 2020, a state of emergency was declared in Japan, as had been by other nations worldwide. This unprecedented crisis has profound implications for patients undergoing chemotherapy and for practicing healthcare professionals. Various reports have shown data indicating that cancer patients with COVID-19 have high morbidity and mortality rates. In order to reduce the use of medical resources to avoid the risk of COVID-19 infections in both cancer patients and health care providers, oncologists now have to draw the line for cancer treatments by maintaining their efficacy while avoiding severe adverse events. In this article, we outlined the decisions made regarding the practice of gastrointestinal oncology in our institution during the COVID pandemic. Springer Singapore 2020-10-21 2021 /pmc/articles/PMC7576109/ /pubmed/33085057 http://dx.doi.org/10.1007/s10147-020-01806-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Article Takahari, Daisuke Shinozaki, Eiji Wakatsuki, Takeru Ooki, Akira Ozaka, Masato Suzuki, Takeshi Nakayama, Izuma Osumi, Hiroki Kamiimabeppu, Daisaku Sato, Taro Ogura, Mariko Suenaga, Mitsukuni Chin, Keisho Yamaguchi, Kensei Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research |
title | Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research |
title_full | Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research |
title_fullStr | Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research |
title_full_unstemmed | Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research |
title_short | Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research |
title_sort | managing a gastrointestinal oncology practice in japan during the covid-19 pandemic: single institutional experience in the cancer institute hospital of japanese foundation for cancer research |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576109/ https://www.ncbi.nlm.nih.gov/pubmed/33085057 http://dx.doi.org/10.1007/s10147-020-01806-7 |
work_keys_str_mv | AT takaharidaisuke managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch AT shinozakieiji managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch AT wakatsukitakeru managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch AT ookiakira managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch AT ozakamasato managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch AT suzukitakeshi managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch AT nakayamaizuma managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch AT osumihiroki managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch AT kamiimabeppudaisaku managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch AT satotaro managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch AT oguramariko managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch AT suenagamitsukuni managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch AT chinkeisho managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch AT yamaguchikensei managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch |